Immunological and molecular study for TLR2 in patients with breast tumors

Authors

  • Dr.wurood Ali Babylon Technical Institute, Al-Furat Al-Awsat Technical University, 51015, Babylon, Iraq Author
  • Dr. Frial Gemeel Abd University of Babylon – collage of sciences – microbiology Author

DOI:

https://doi.org/10.61856/9qgkhf18

Keywords:

Breast tumor , TLR2, local and systemic immunity , genetic polymorphism (sequencing ).

Abstract

A tumor is a mass of abnormal tissue. There are two types of breast cancer tumors: those that are non-cancerous, or ‘benign’, and those that are cancerous, which are ‘malignant’ Seventy (70) biopsy  of  breast tumors  patients women without chemotherapy for DNA extraction for genetic polymorphism of TLR2 and local immunity study for TLR2 , fifty (50) blood sample from healthy women as control group.  One hundred (100) blood sample from women with breast tumor for   polymorphism of TLR2 and   evaluated  immune markers (TLR2).The age  of women in this study ranging from (14-66) years in AL-Hilla-Teaching hospital , Imam Sadiq Hospital and  Marjan hospital  a period from September 2021 to October 2022.the result appearedthat By Enzyme Linked Immunosorbent Assay technique showed that the concentration of TLR2 in  serum patients were (9.953±4.606)  significantly increased  compare with control (6.774±3.855 )respectively, The concentrations of TLR2 in  serum patients were (5.599±3.550)  significantly different  compare with concentrations tissue (21.000 ±14.356 )respectively , For TLR2  196 to 174 del  genotyping the result was significantly only  deletion in (G, C , T ) between patients with chemotherapy and control ) at (p =0.003* , 0.0007* , 0.04*) respectively , also the result significantly for insertion of (G) between patients with chemotherapy and control ) at (p =0.01* )

Author Biography

  • Dr. Frial Gemeel Abd, University of Babylon – collage of sciences – microbiology

    department of biology college of scines 

References

Al Harras ,M.F.; Houssen ,M.E.; Shaker ,M.E.; Farag ,K.;arouk ,O.; Monir ,R.; El Mahdy ,R and Abo Hashem ,E.M.(2016). Polymorphisms of glutathione S transferase π 1 and toll like receptors 2 and 9: Association with breast cancer susceptibility. Oncol Lett 11: 2182 2188. doi: 10.3892/ol.2016.4159. Epub 2016 Jan 28. PMID: 26998146; PMCID: PMC4774482.

Ali Ghalib ,H.H.; Ali ,D.H.; Molah Karim, S.A.; Mohialdeen Gubari ,M.I.; Mohammed ,S.A.; Marif ,D.H and Othman ,H.M.(2019). Risk factors assessment of breast cancer among Iraqi Kurdish women: Case-control study. Journal of Family Medicine and Primary Care. 10;8(12):3990-3997. doi: 10.4103/jfmpc.jfmpc_528_19. PMID: 31879648; PMCID: PMC6924248.

Azzollini ,J.; Fontana, L and Manoukian ,S.(2020). Hereditary breast cancer: BRCA and Other Susceptibility Genes. In Breast MRI for Highrisk Screening. 23-41.

Alamri, A.M.; Alsareii ,S.A.; Al-Wadei ,H.H.; Al-Qahtani,A.M.; Sultan,S.A.A.; Alshamrani ,S.A.; Almakrami , A.H.; Daiel,A.A.; Alyami ,A.Y.; Hommadi,A.M and Ali ,Y.A.T. (2020).Epidemiological pattern of breast diseases among females in the South-Western Region, Saudi Arabia International Journal of Clinical Medicine, 11, 257-269. DOI: 10.4236/ijcm.2020.115027

Alwan ,N.(2014). Iraqi initiative of a regional comparative breast cancer research project in the Middle East. Journal of Cancer Biology & Research. 2(1):1016.

Al-Rawi, N.A.S.(2013). A retrospective study of surgical breast tumors in Iraq . Tikrit Medical Journal;19(2): 346-352

Brubaker ,S.W.; Bonham ,K.S.; Zanoni ,I and Kagan ,J.C.( 2015). Innate immune pattern recognition: A cell biological perspective. Annual Review of Immunology. 33:257–290. doi: 10.1146/annurev-immunol-032414-112240. Epub 2015 Jan 2.

Abdulsamad , H.H.; Al-Hawwaz , M.H and Mahmoud, R.A.(2021). Breast cancer among women in basrah , Iraq : A descriptive study in brade 1 and 2 screened case. Breast cancer among women in Basrah.27. Basrah Journal of Surgery, 27.

Abdulabbas, N.F and Shani ,W.S.(2022). Evaluation of soluble toll-Like receptors 2, 4, 9 and their damps signaling molecules (HMGB1 & HSP70) in breast cancer patients of Basrah province Iranian Journal of Breast Disease s . 15(2):50-62. http://ijbd.ir/article-1-976-en.html

Al-Ammiri ,H.H and Al-Derzi ,A.R.(2013). Validity of serum toll-like receptor-2 (TLR-2) in women with breast tumor. Journal of the Faculty of Medicine Baghdad . 1 ;55(2):152-7. DOI: https://doi.org/10.32007/jfacmedbagdad.552645

Bhattacharya ,D and Yusuf ,N.(2012). Expression of toll like receptors on breast tumors: Taking a toll on tumor microenvironment. International Journal of Breast Cancer: 716564. doi: 10.1155/2012/716564. Epub 2011 Nov 9. PMID: 22295250; PMCID: PMC3262598.

Chow ,A., Zhou ,W., Liu ,L., Fong, M.Y., Champer ,J., Van Haute ,D., Chin ,A.R., Ren ,X., Gugiu ,B.G., Meng ,Z., Huang ,W., Ngo ,V., Kortylewski ,M and Wang ,S.E.(2014). Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB. Scientific Reports. 18;4:5750. doi: 10.1038/srep05750. PMID: 25034888; PMCID: PMC4102923.

Comen ,E.A.; Bowman ,R.L and Kleppe ,M.(2018). Underlying causes and Therapeutic targeting of the inflammatory tumor microenvironment. Frontiers in Cell and Developmental Biology. ,6:56. doi: 10.3389/fcell.2018.00056.

Degnim ,A.C., Brahmbhatt ,R.D., Radisky ,D.C., Hoskin ,T.L., Stallings-Mann ,M., Laudenschlager ,M., Mansfield ,A., Frost ,M.H., Murphy ,L., Knutson ,K and Visscher ,D.W.(2014). Immune cell quantitation in normal breast tissue lobules with and without lobulitis. Breast Cancer Research and Treatment ;144(3):539-49. doi: 10.1007/s10549-014-2896-8. Epub 2014 Mar 5

El-Kharashy ,G.; Gowily ,A.; Okda ,T and Houssen ,M.(2021). Association between serum soluble toll-like receptor 2 and 4 and the risk of breast cancer. Molecular and Clinical Oncology 14(2):38. doi: 10.3892/mco.2020.2200. Epub 2020 Dec 24. PMID: 33414918; PMCID: PMC7783720.

Huang ,B.; Zhao ,J.; Unkeless ,J.C.; Feng ,Z.H and Xiong ,H.(2008). TLR signaling by tumor and immune cells: A double-edged sword. Oncogene. 27:218–224. doi: 10.1038/sj.onc.1210904. PMID: 18176603.

Hatim, K.S., Laxmikant, N.S. and Mulla, T. (2017) Patterns and prevalence of benign breast disease in Western India. International Journal of Research in Medical Sciences, 5, 684-688. https://doi.org/10.18203/2320 6012.ijrms20170174

Hsieh ,C.C.; Pavia ,M.; Lambe ,M.; Lan ,S.J.; Colditz ,G.A.; Ekbom ,A.; Adami ,H.O.; Trichopoulos ,D and Willett ,W.C.(1994). Dual effect of parity on breast cancer risk. European journal of Cancer ; 30(7):969-73. doi: 10.1016/0959-8049(94)90125-2. PMID: 7946593.

Houssen ,M.E.; El Mahdy ,R.H and Shahin ,D.A.(2016). Serum soluble toll like receptor 2: A novel biomarker for systemic lupus erythematosus disease activity and lupus related cardiovascular dysfunction. International Journal of Rheumatic Diseases 19: 685 692 . doi: 10.1111/1756-185X.12452. Epub 2014 Aug 14. PMID: 25123610.

Huber ,M.A., Azoitei ,N., Baumann ,B., Grünert ,S., Sommer ,A., Pehamberger ,H., Kraut ,N., Beug ,H and Wirth ,T.(2004). NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. Journal of Clinical Investigation. 114(4):569-81. doi: 10.1172/JCI21358. PMID: 15314694; PMCID: PMC503772.

Johnston ,D.G and Corr, S.C(2016). Toll-like receptor signaling and the control of intestinal barrier function. Methods Molecular Biology. 1390:287–300. doi: 10.1007/978-1-4939-3335-8_18. PMID: 26803636.

Johansson ,A., Christakou ,A.E., Iftimi, A., Eriksson ,M., Tapia ,J., Skoog ,L., Benz ,C.C., Rodriguez-Wallberg ,K.A., Hall ,P., Czene ,K and Lindström ,L.S.(2021). Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden. JAMA Network Open.1;4(6): 2114716. doi:10.1001/jamanetworkopen.2021.14716. PMID: 34170304; PMCID: PMC8233703.

Kumar ,M.; Ray ,K.; Harode ,S and Wagh, D.D.(2010). The Pattern of benign breast diseases in Rural Hospital in India. East and Central African J Sur;15(2):59-64

Katalinic, A.; Eisemann, N.; Kraywinkel, K.; Maria, R.; Noft, z and Hübner.J. (2019).Breast cancer incidence and mortality before and after implementation of the German mammography screening program the periodontal pathogen Porphyromonas gingivalis. Cytokine. 76:424–432. doi: 10.1111/j.1365-2222.2004.01839.x. PMID: 14987294.

Lu ,H., Yang ,Y., Gad ,E., Inatsuka ,C., Wenner ,C.A., Disis ,M.L and Standish ,L.J.(2011). TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clinical Cancer Research ;17(21):6742-53. doi: 10.1158/1078-0432.CCR-11-1142. Epub 2011 Sep 14. PMID: 21918170; PMCID: PMC3206987.

Lim ,B.; Woodward ,W.A.; Wang ,X.; Reuben ,J.M and Ueno ,N.T.(2018). Inflammatory breast cancer biology: The tumour microenvironment is Key. Nature Reviews Cancer . 18(8):485–99.doi: 10.1038/s41568-018-0010-Erratum in: Nat Rev Cancer. 2018 May 10

Mifsud ,E. Jand Tan ,A.C and Jackson ,D.C.(2014). TLR Agonists as modulators of the innate immune response and their potential as agents against infectious disease. Front Immunology. 5:79.doi.org/10.3389/fimmu.2014.00079

Majid ,R.A., Hassan ,H.A., Muhealdeen ,D.N., Mohammed ,H.A and Hughson MD.(2017). Breast cancer in Iraq is associated with a unimodally distributed predominance of luminal type B over luminal type A surrogates from young to old age. BMC Womens Health. 7;17(1):27. doi: 10.1186/s12905-017-0376-0. PMID: 28388952; PMCID: PMC5383947.

Noguchi ,E.; Nishimura ,F.; Fukai ,H.; Kim ,J.; Ichikawa ,K.; Shibasaki, M and Arinami ,T.(2004). An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clinical & Experimental Allergy. 34:177–183. doi: 10.1111/j.1365-2222.2004.01839.x. PMID: 14987294.

Nada A. S and Alwan .(2010). Iraqi Breast Cancer: A Review on Patients' Demographic Characteristics and Clinico-Pathological Presentation. Journal of the Faculty of Medicine Baghdad . 52 . 1.

Orta, T and Günebakan, S. (2012). The effect of aging on micronuclei frequency and proliferation in human peripheral blood

lymphocytes. Indian Journal of Human Genetics., 18(1): 95. doi: 10.4103/0971-6866.96671. PMID: 22754230; PMCID: PMC3385189.

Palm, E, Demirel ,I, Bengtsson ,T, Khalaf ,H.(2015). The role of toll-like and protease-activated receptors in the expression of cytokines by gingival fibroblasts stimulated with the periodontal pathogen Porphyromonas gingivalis. Cytokine. 2 Dec;76(2):424-432. doi: 10.1016/j.cyto.2015.08.263. Epub 2015 Aug 28. PMID: 26318255.

Rasheed ,A.; Sharma ,S.; Mohsin-ul-Rasool, Bashir ,S.; Hafiz ,A and BashirSch ,N. (2014).A Three year study of breast lesions in women aged 15-70 years in a Tertiary Care Hospital. Journal of Applied Medical Sciences .;2(1):166-8. DOI: 10.36347/sjams.2014.v02i01.0034

Sangma ,M.B.M.; Panda ,K and Dasiah ,S. (2013).A Clinico Pathological Study on Benign Breast Diseases. Journal of Clinical and Diagnostic Research. 7(3):503-6. doi: 10.7860/JCDR/2013/5355.2807. Epub 2013 Jan 10. PMID: 23634406; PMCID: PMC3616566.

Todoric ,J.; Antonucci ,L and Karin ,M. (2016) . Targeting inflammation in cancer prevention and therapy. Cancer Prevention Research (Phila) . 9(12):895–905. doi: 10.1158/1940-6207.CAPR-16-0209. Epub 2016 Nov 10.

Wang ,J.; Shi ,Y.; Wang ,G.; Dong, S.; Yang ,D and Zuo ,X.(2019). The association between interleukin‐1 polymorphisms and their protein expression in Chinese Han patients with breast cancer. Molecular Genetics & Genomic Medicine. 7:e804. doi: 10.1002/mgg3.804. Epub 2019 Jul 11. PMID: 31297985; PMCID: PMC6687616.

Wojda, A.; Ziętkiewicz, E.; Mossakowska, M.; Pawłowski, W.;

Skrzypczak, K. and Witt, M. (2006). Correlation between the level

of cytogenetic aberrations in cultured human lymphocytes and the age and gender of donors. The Journals of Gerontology: Biological Sciences Medical Sciences., 61(8): 763-772. https://doi.org/10.1093/gerona/61.8.763

Xie,W., Wang, Y., Huang,Y., Yang,H., Wang, J and Hu , Z.(2009).Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells, Biochemical and Biophysical Research Communications, 379( 4) : 1027-1032. doi: 10.1016/j.bbrc.2009.01.009. Epub 2009 Jan 12. PMID: 19141294.

Yusuf ,N.(2014). Toll-like receptors and breast cancer. Front Immunol 5: 84. doi: 10.3389/fimmu.2014.00224

Zhu ,L.; Yuan ,H.; Jiang ,T.; Wang ,R.; Ma ,H and Zhang, S.(2013). Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis. PLoS ONE.8:e82858.https://doi.org/10.1371/journal.pone.0082858

Downloads

Published

15-03-2024

How to Cite

Ali, W., & Gemeel Abd, F. (2024). Immunological and molecular study for TLR2 in patients with breast tumors. International Innovations Journal of Applied Science, 1(1). https://doi.org/10.61856/9qgkhf18

Similar Articles

You may also start an advanced similarity search for this article.